← Leaderboards
Michael H. Weisman
La Biomed Res Inst/ Harbor Ucla Med Ctr
$2,900,399
Attributed
$2,900,399
Total exposure
26
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $480.1K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,900,399 · 26
By mechanism
M01$1,702,029 · 25
R01$1,198,370 · 1
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Thomas M Ernst$23,754,146
- John S. Adams$12,304,676
- Craig D Newgard$13,323,909
- Christina C. Wang$7,924,844
- David L Rimoin$8,381,773
Others in their field
Top investigators on “Rheumatoid Arthritis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Lionel B Ivashkiv · Hospital For Special Surgery$38,096,851
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- V Michael Holers · University Of Colorado Denver$28,178,502
- Michael B Brenner · Brigham And Women'S Hospital$26,598,289
- Betty Diamond · Feinstein Institute For Medical Research$20,428,564
Research focus
Rheumatoid ArthritisResourcesInstitutionResearch PersonnelFundingUnited States National Institutes Of HealthSourceComputer Retrieval Of Information On Scientific Projects DatabaseGrantAffectClinical ResearchQuestionnairesGenetic MarkersVisitHuman SubjectSpondylitisUniversitiesGenetic SusceptibilityEnrollmentFutureFamily GeneticsScreening ProcedurePersonsInflammation
Grant awards (34)
A COMPREHENSIVE MODEL OF SEVERITY IN OUTCOMES IN ANKYLOSING SPONDYLITIS$211,949
M01 · FY2010 · RR · contact PI
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS$202,732
M01 · FY2010 · RR · contact PI
PROJECT 3: DEFINING THE SPECTRUM OF SPONDYLOARTHRITIS IN FAMILY MEMBERS$29,489
M01 · FY2010 · RR · contact PI
INFLAMMATORY MARKERS IN THE STOOL AND SERUM OF PATIENTS WITH ANKYLOSING SPONDYLI$19,352
M01 · FY2010 · RR · contact PI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$16,587
M01 · FY2010 · RR · contact PI
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS$202,904
M01 · FY2009 · RR · contact PI
A COMPREHENSIVE MODEL OF SEVERITY IN OUTCOMES IN ANKYLOSING SPONDYLITIS$174,981
M01 · FY2009 · RR · contact PI
PROJECT 3: DEFINING THE SPECTRUM OF SPONDYLOARTHRITIS IN FAMILY MEMBERS$96,799
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: BEHAVIORAL TREATMENTS FOR RHEUMATOID ARTHRITIS$3,722
M01 · FY2009 · RR · contact PI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES$930
M01 · FY2009 · RR · contact PI
A COMPREHENSIVE MODEL OF SEVERITY IN OUTCOMES IN ANKYLOSING SPONDYLITIS$112,567
M01 · FY2008 · RR · contact PI
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS$94,294
M01 · FY2008 · RR · contact PI
GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY: CROSS SECTIONAL STUDY$27,045
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: BEHAVIORAL TREATMENTS FOR RHEUMATOID ARTHRITIS$16,813
M01 · FY2008 · RR · contact PI
GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY: CROSS SECTIONAL STUDY$58,321
M01 · FY2007 · RR · contact PI
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS$31,319
M01 · FY2007 · RR · contact PI
BEHAVIORAL TREATMENTS FOR RHEUMATOID ARTHRITIS$12,600
M01 · FY2007 · RR · contact PI
GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY: CROSS SECTIONAL STUDY$110,326
M01 · FY2006 · RR · contact PI
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS$38,021
M01 · FY2006 · RR · contact PI
BEHAVIORAL TREATMENTS FOR RHEUMATOID ARTHRITIS$35,529
M01 · FY2006 · RR · contact PI
EFFICACY OF CAM INTERVENTION IN RHEUMATOID ARTHRITIS$10,597
M01 · FY2006 · RR · contact PI
Genetic Determinants of Ankylosing Spondylitis Severity$293,954
R01 · FY2005 · AR
GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY: CROSS SECTIONAL STUDY$74,394
M01 · FY2005 · RR
BEHAVIORAL TREATMENTS FOR RHEUMATOID ARTHRITIS$34,045
M01 · FY2005 · RR
FAMILY STUDIES OF MICROSATELLITE GENE MARKERS IN PATIENTS WITH ANKYLOSING$22,697
M01 · FY2005 · RR
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS:STUD$9,457
M01 · FY2005 · RR
Genetic Determinants of Ankylosing Spondylitis Severity$293,465
R01 · FY2004 · AR
Genetic Determinants of Ankylosing Spondylitis Severity: Cross Sectional Study$44,931
M01 · FY2004 · RR
Family Studies of Microsatellite Gene Markers in Patients with Ankylosing$9,628
M01 · FY2004 · RR
Genetic Determinants of Ankylosing Spondylitis Severity$292,795
R01 · FY2003 · AR
Genetic Determinants of Ankylosing Spondylitis Severity$318,156
R01 · FY2002 · AR
Family studies of microsatellite gene markers in ankylosing spondylitis$0
M01 · FY2000 · RR
Family studies of microsatellite gene markers in ankylosing spondylitis$0
M01 · FY2000 · RR
Family studies of microsatellite gene markers in ankylosing spondylitis$0
M01 · FY2000 · RR